192 related articles for article (PubMed ID: 1395739)
41. Help yourself defeat the lung infection called PCP. National Institutes of Health.
AIDS Alert; 1997 Feb; 12(2):suppl 1. PubMed ID: 11364036
[TBL] [Abstract][Full Text] [Related]
42. [Pneumocystis carinii infection during prophylaxis with nebulized pentamidine in a patient with AIDS].
de Jong MD; Lange JM; Smits NJ; Reiss P
Ned Tijdschr Geneeskd; 1991 Mar; 135(10):424-7. PubMed ID: 2020315
[TBL] [Abstract][Full Text] [Related]
43. Characteristics of hospital admissions for pneumonia in HIV-positive individuals in Winnipeg, Manitoba: a cross-sectional retrospective analysis.
van Gaalen S; Duff M; Arroyave LF; Rueda ZV; Kasper K; Keynan Y
Int J STD AIDS; 2018 Feb; 29(2):115-121. PubMed ID: 28661231
[TBL] [Abstract][Full Text] [Related]
44. [Pneumocystis carinii pneumonia and HIV infection: diagnosis and treatment].
González-García J; Rubio García R; Antela López A; García Alcaide F
Enferm Infecc Microbiol Clin; 1998; 16 Suppl 1():36-44. PubMed ID: 9859618
[TBL] [Abstract][Full Text] [Related]
45. A randomized comparison of once-monthly or twice-monthly high-dose aerosolized pentamidine prophylaxis.
Golden JA; Katz MH; Chernoff DN; Duncan SM; Conte JE
Chest; 1993 Sep; 104(3):743-50. PubMed ID: 8365284
[TBL] [Abstract][Full Text] [Related]
46. Aerosolized pentamidine prophylaxis against AIDS-related Pneumocystis carinii pneumonia and its short- and long-term effects on pulmonary function in the Japanese.
Konishi M; Yoshimoto E; Takahashi K; Uno K; Kasahara K; Murakawa K; Maeda K; Mikasa K; Narita N
J Infect Chemother; 2003 Jun; 9(2):178-82. PubMed ID: 12825119
[TBL] [Abstract][Full Text] [Related]
47. Pneumocystis carinii pneumonia presenting as focal bibasilar uptake on gallium scan during aerosolized pentamidine prophylaxis.
Katial R; Honeycutt W; Oswald SG
J Nucl Med; 1994 Jun; 35(6):1038-40. PubMed ID: 8195865
[TBL] [Abstract][Full Text] [Related]
48. Low incidence of community-acquired pneumonia among human immunodeficiency virus-infected patients after interruption of Pneumocystis carinii pneumonia prophylaxis.
Eigenmann C; Flepp M; Bernasconi E; Schiffer V; Telenti A; Bucher H; Wagels T; Egger M; Furrer H;
Clin Infect Dis; 2003 Apr; 36(7):917-21. PubMed ID: 12652393
[TBL] [Abstract][Full Text] [Related]
49. How successful are we in administering prophylaxis against Pneumocystis carinii pneumonia (PCP) in patients with HIV infection?
Knowles C; East-Innis A; Bradbeer CS; Bateman NT
Int J STD AIDS; 1997 May; 8(5):345-6. PubMed ID: 9175661
[No Abstract] [Full Text] [Related]
50. Pneumonia in the patient with HIV infection.
Bartlett JG
Infect Dis Clin North Am; 1998 Sep; 12(3):807-20, xi. PubMed ID: 9779391
[TBL] [Abstract][Full Text] [Related]
51. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with human immunodeficiency virus.
MMWR Recomm Rep; 1991 Mar; 40(RR-2):1-13. PubMed ID: 1672036
[TBL] [Abstract][Full Text] [Related]
52. Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995: comparison of HIV-associated cases to other immunocompromised states.
Mansharamani NG; Garland R; Delaney D; Koziel H
Chest; 2000 Sep; 118(3):704-11. PubMed ID: 10988192
[TBL] [Abstract][Full Text] [Related]
53. Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia. The San Francisco community prophylaxis trial.
Leoung GS; Feigal DW; Montgomery AB; Corkery K; Wardlaw L; Adams M; Busch D; Gordon S; Jacobson MA; Volberding PA
N Engl J Med; 1990 Sep; 323(12):769-75. PubMed ID: 1975426
[TBL] [Abstract][Full Text] [Related]
54. Pneumocystis carinii pneumonia in HIV-infected patients in the HAART era.
Pulvirenti J; Herrera P; Venkataraman P; Ahmed N
AIDS Patient Care STDS; 2003 Jun; 17(6):261-5. PubMed ID: 12880489
[TBL] [Abstract][Full Text] [Related]
55. [Primary and secondary prevention of Pneumocystis carinii pneumonia with pentamidine aerosol. Effectiveness, side effects and incidence of extrapulmonary Pneumocystis carinii manifestations].
Stoehr A; Plettenberg A; Albrecht H; Stellbrink HJ; Meigel W; Begemann F
Med Klin (Munich); 1994 Mar; 89(3):132-5. PubMed ID: 8196573
[TBL] [Abstract][Full Text] [Related]
56. Clinical and laboratory correlates of Pneumocystis carinii pneumonia in children infected with HIV.
Connor E; Bagarazzi M; McSherry G; Holland B; Boland M; Denny T; Oleske J
JAMA; 1991 Apr; 265(13):1693-7. PubMed ID: 1672168
[TBL] [Abstract][Full Text] [Related]
57. The role of aerosol pentamidine prophylaxis.
Ong EL
Int J STD AIDS; 1993; 4(2):67-9. PubMed ID: 8476968
[TBL] [Abstract][Full Text] [Related]
58. Pneumocystis jiroveci pneumonia prophylaxis is not required with a CD4+ T-cell count < 200 cells/microl when viral replication is suppressed.
D'Egidio GE; Kravcik S; Cooper CL; Cameron DW; Fergusson DA; Angel JB
AIDS; 2007 Aug; 21(13):1711-5. PubMed ID: 17690568
[TBL] [Abstract][Full Text] [Related]
59. Pneumocystis pneumonia in HIV-1-infected patients.
Shibata S; Kikuchi T
Respir Investig; 2019 May; 57(3):213-219. PubMed ID: 30824356
[TBL] [Abstract][Full Text] [Related]
60. Pneumocystis carinii pneumonia among US children with perinatally acquired HIV infection.
Simonds RJ; Oxtoby MJ; Caldwell MB; Gwinn ML; Rogers MF
JAMA; 1993 Jul; 270(4):470-3. PubMed ID: 8320786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
